105 related articles for article (PubMed ID: 7786779)
1. Evidence for a paracrine pathway of B-cell stimulation in hairy cell leukaemia.
Schmid M; Schrezenmeier H; Staib G; Porzsolt F
Br J Haematol; 1995 May; 90(1):156-62. PubMed ID: 7786779
[TBL] [Abstract][Full Text] [Related]
2. Paracrine regulation of B-cell growth in hairy cell leukemia.
Porzsolt F; Schmid M; Staib G; Schrezenmeier H
Leuk Lymphoma; 1994; 14 Suppl 1():13-8. PubMed ID: 7820045
[TBL] [Abstract][Full Text] [Related]
3. Abnormally activated T lymphocytes in the spleen of patients with hairy-cell leukemia.
Kluin-Nelemans JC; Kester MG; Oving I; Cluitmans FH; Willemze R; Falkenburg JH
Leukemia; 1994 Dec; 8(12):2095-101. PubMed ID: 7807997
[TBL] [Abstract][Full Text] [Related]
4. B cell growth factor-induced proliferation of hairy cell lymphocytes and inhibition by type I interferon in vitro.
Paganelli KA; Evans SS; Han T; Ozer H
Blood; 1986 Apr; 67(4):937-42. PubMed ID: 2937473
[TBL] [Abstract][Full Text] [Related]
5. Effects of interferon alpha on autocrine growth factor loops in B lymphoproliferative disorders.
Heslop HE; Bianchi AC; Cordingley FT; Turner M; Chandima W; De Mel CP; Hoffbrand AV; Brenner MK
J Exp Med; 1990 Dec; 172(6):1729-34. PubMed ID: 2258703
[TBL] [Abstract][Full Text] [Related]
6. Autocrine and paracrine regulation of neoplastic cell growth in hairy cell leukemia.
Schmid M; Porzsolt F
Leuk Lymphoma; 1995 May; 17(5-6):401-10. PubMed ID: 7549830
[TBL] [Abstract][Full Text] [Related]
7. alpha-Interferon inhibits spontaneous and induced DNA synthesis in hairy cell leukemia.
Hassan IB; Gronowitz JS; Carlsson M; Sundström C
Leuk Lymphoma; 1992 May; 7(1-2):69-77. PubMed ID: 1472934
[TBL] [Abstract][Full Text] [Related]
8. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
9. Possible mechanism of action of interferon alpha in chronic B-cell malignancies.
Heslop HE; Brenner MK; Ganeshaguru K; Hoffbrand AV
Br J Haematol; 1991 Oct; 79 Suppl 1():14-6. PubMed ID: 1931702
[TBL] [Abstract][Full Text] [Related]
10. Hyperphosphorylation of CD20 in hairy cells. Alteration by low molecular weight B cell growth factor and IFN-alpha.
Genot E; Valentine MA; Degos L; Sigaux F; Kolb JP
J Immunol; 1991 Feb; 146(3):870-8. PubMed ID: 1703183
[TBL] [Abstract][Full Text] [Related]
11. Effects of tumour necrosis factor and alpha interferon on chronic B cell malignancies.
Bianchi AC; Heslop HE; Drexler HG; Cordingley FT; Turner M; De Mel WC; Hoffbrand AV; Brenner MK
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):317-9. PubMed ID: 3265501
[TBL] [Abstract][Full Text] [Related]
12. Residual T lymphocytes, and not malignant B cells, proliferate upon mitogenic stimulation.
Kluin-Nelemans HC; Jansen JH
Leukemia; 1989 Oct; 3(10):715-7. PubMed ID: 2789326
[TBL] [Abstract][Full Text] [Related]
13. Inadequate production of hematopoietic growth factors in hairy cell leukemia: up-regulation of interleukin 6 by recombinant IFN-alpha in vitro.
Schwarzmeier JD; Hilgarth M; Nguyen ST; Shehata M; Gruber G; Spittler A; Willheim M; Boltz-Nitulescu G; Höcker P; Berger R
Cancer Res; 1996 Oct; 56(20):4679-85. PubMed ID: 8840984
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-7 is a potent co-stimulus of the adhesion pathway involving CD2 and CD28 molecules.
Costello R; Brailly H; Mallet F; Mawas C; Olive D
Immunology; 1993 Nov; 80(3):451-7. PubMed ID: 7904590
[TBL] [Abstract][Full Text] [Related]
15. Production of tumor necrosis factor-alpha by normal and malignant B lymphocytes in response to interferon-alpha, interferon-gamma and interleukin-4.
Jansen JH; Wientjens GJ; Willemze R; Kluin-Nelemans JC
Leukemia; 1992 Feb; 6(2):116-9. PubMed ID: 1552742
[TBL] [Abstract][Full Text] [Related]
16. Growth factor-mediated tumor cell proliferation in hairy cell leukemia.
Ford RJ; Yoshimura L; Morgan J; Quesada J; Montagna R; Maizel A
J Exp Med; 1985 Sep; 162(3):1093-8. PubMed ID: 2993470
[TBL] [Abstract][Full Text] [Related]
17. Cytokine-induced enhancement of the susceptibility of hairy cell leukaemia lymphocytes to natural killer cell lysis.
Cordingley FT; Hoffbrand AV; Brenner MK
Br J Haematol; 1988 Sep; 70(1):37-41. PubMed ID: 3140887
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies.
Cordingley FT; Bianchi A; Hoffbrand AV; Reittie JE; Heslop HE; Vyakarnam A; Turner M; Meager A; Brenner MK
Lancet; 1988 Apr; 1(8592):969-71. PubMed ID: 2896830
[TBL] [Abstract][Full Text] [Related]
19. Effects of anti-TNF monoclonal antibody infusion in patients with hairy cell leukaemia.
Huang D; Reittie JE; Stephens S; Hoffbrand AV; Brenner MK
Br J Haematol; 1992 Jun; 81(2):231-4. PubMed ID: 1379467
[TBL] [Abstract][Full Text] [Related]
20. Human B cells and macrophages cooperate in T-cell-independent type 2 response.
Mättö M; Raunio AR; Postila V; Huttunen K; Hirvonen MR; Pelkonen J
Scand J Immunol; 2008 Mar; 67(3):209-17. PubMed ID: 18194360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
